BCTX - BriaCell Therapeutics Corp.
3.86
-0.150 -3.886%
Share volume: 186,040
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$4.01
-0.15
-0.04%
Summary score
53%
Profitability
35%
Dept financing
38%
Liquidity
50%
Performance
75%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-27.69%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
90.37%
Debt ratio change over timeo
0%
Current Ratio
14.85%
Quick Ratio
0%
Cash Position Ratio
13.4%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-50.97%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
32.4%
Debt ratio change over timeo
0%
Current Ratio
3.3%
Quick Ratio
0%
Cash Position Ratio
1.82%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-62.97%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
23.69%
Debt ratio change over time
0%
Current Ratio
3.42%
Quick Ratio
0%
Cash Position Ratio
0.82%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 10.6% | 11.11% | 0% |
| Return on assets | -27.69% | 4.69% | 3.16% | 1.47% |
| Return on sales | 0% | 30.75% | 25.13% | 22.8% |
| Return on invested capital | 0% | 7.36% | 11.75% | 0% |
| Profitability | 0% | 90% | 87% | 26% |
| Total debt ratio | 90.37% | 80.39% | 59.46% | 95.26% |
| Debt ratio change over time | 0% | -25.01% | -101.26% | 0% |
| Dept financing | 49% | 21% | 16% | 25% |
| Current Ratio | 3.3% | 1.47% | 1.04% | 0.71% |
| Quick Ratio | 0% | 1.14% | 0.77% | 0.59% |
| Cash Position Ratio | 1.82% | 0.18% | 0.36% | 0.14% |
| Liquididy | 50% | 27% | 26% | 20% |
| Short-term ratios | BCTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -50.97% | 6.79% | 3.25% | 1.71% |
| Return on sales | 0% | 43.13% | 26.46% | 23.71% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 27% | 20% |
| Total debt ratio | 32.4% | 79.21% | 59.12% | 101.52% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 33% | 20% | 15% | 25% |
| Current Ratio | 3.3% | 1.47% | 1.04% | 0.71% |
| Quick Ratio | 0% | 1.14% | 0.77% | 0.59% |
| Cash Position Ratio | 1.82% | 0.18% | 0.36% | 0.14% |
| Liquididy | 50% | 39% | 30% | 20% |